The present application belongs to the field of
medicine and
biotechnology, and particularly relates to the use of
matrine in the preparation of a
medicine for preventing or treating
radiation damage. The
radiation damage includes
skin damage,
lung damage, intestinal damage, hematopoietic damage,
reproductive function damage, and delaying aging caused by
radiation. The radiation includes non-
ionizing radiation and
ionizing radiation. The
medicine further comprises other medicines for preventing or treating
radiation damage. In the screening of anti-radiation medicines based on various
cell models, it is found that
matrine has a repair-promoting effect on small intestinal mucosal epithelial
cell damage caused by radiation; through a mouse
radiation damage model, it is found that
matrine can effectively protect the body, reduce the death caused by a
lethal dose of Co-60 gamma rays, and
delay aging caused by radiation.
Matrine has a good clinical application prospect in preventing or treating
radiation damage, and has no obvious toxic side effects.